AKUMIN INC (AKU)
US01021X1000 - Common Stock
We assign a fundamental rating of 3 out of 10 to AKU. AKU was compared to 109 industry peers in the Health Care Providers & Services industry. AKU may be in some trouble as it scores bad on both profitability and health. AKU is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AKU has reported negative net income.
In the past year AKU had a positive cash flow from operations.
In the past 5 years AKU reported 4 times negative net income.
Each year in the past 5 years AKU had a positive operating cash flow.
1.2 Ratios
AKU's Return On Assets of -9.35% is on the low side compared to the rest of the industry. AKU is outperformed by 66.96% of its industry peers.
With a Return On Invested Capital value of 2.58%, AKU perfoms like the industry average, outperforming 53.91% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AKU is significantly below the industry average of 8.16%.
The last Return On Invested Capital (2.58%) for AKU is above the 3 year average (1.89%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.35% | ||
| ROE | N/A | ||
| ROIC | 2.58% |
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
1.3 Margins
AKU has a better Operating Margin (6.78%) than 72.17% of its industry peers.
In the last couple of years the Operating Margin of AKU has grown nicely.
AKU has a Gross Margin (25.32%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AKU has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 25.32% |
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKU is destroying value.
The number of shares outstanding for AKU has been increased compared to 1 year ago.
Compared to 1 year ago, AKU has a worse debt to assets ratio.
2.2 Solvency
AKU has an Altman-Z score of 0.30. This is a bad value and indicates that AKU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AKU (0.30) is worse than 66.96% of its industry peers.
AKU has a debt to FCF ratio of 59.58. This is a negative value and a sign of low solvency as AKU would need 59.58 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 59.58, AKU is in line with its industry, outperforming 46.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 59.58 | ||
| Altman-Z | 0.3 |
ROIC/WACC0.59
WACC4.35%
2.3 Liquidity
AKU has a Current Ratio of 1.09. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
AKU's Current ratio of 1.09 is on the low side compared to the rest of the industry. AKU is outperformed by 70.43% of its industry peers.
A Quick Ratio of 1.09 indicates that AKU should not have too much problems paying its short term obligations.
The Quick ratio of AKU (1.09) is worse than 61.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The earnings per share for AKU have decreased strongly by -118.41% in the last year.
The Revenue has grown by 38.20% in the past year. This is a very strong growth!
Measured over the past years, AKU shows a very strong growth in Revenue. The Revenue has been growing by 59.26% on average per year.
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%
3.2 Future
The Earnings Per Share is expected to grow by 29.98% on average over the next years. This is a very strong growth
AKU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AKU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AKU. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKU indicates a rather cheap valuation: AKU is cheaper than 81.74% of the companies listed in the same industry.
AKU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AKU is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.18 | ||
| EV/EBITDA | 8.75 |
4.3 Compensation for Growth
A more expensive valuation may be justified as AKU's earnings are expected to grow with 29.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3YN/A
5. Dividend
5.1 Amount
AKU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AKUMIN INC
NASDAQ:AKU (10/25/2023, 8:00:00 PM)
After market: 0.2875 0 (-0.42%)0.2887
-0.06 (-17.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0%
Inst Owner Change0%
Ins Owners15.75%
Ins Owner Change0%
Market Cap25.84M
Analysts45
Price Target0.92 (218.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-60.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | 1.18 | ||
| P/OCF | 0.44 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.75 |
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)0.25
FCFY84.98%
OCF(TTM)0.66
OCFY229.66%
SpS8.39
BVpS-0.93
TBVpS-13.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.35% | ||
| ROE | N/A | ||
| ROCE | 3.26% | ||
| ROIC | 2.58% | ||
| ROICexc | 2.65% | ||
| ROICexgc | 11.22% | ||
| OM | 6.78% | ||
| PM (TTM) | N/A | ||
| GM | 25.32% | ||
| FCFM | 2.92% |
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
ROICexc(3y)1.99%
ROICexc(5y)2.97%
ROICexgc(3y)6.74%
ROICexgc(5y)9.33%
ROCE(3y)2.39%
ROCE(5y)3.5%
ROICexcg growth 3Y33.83%
ROICexcg growth 5Y32.54%
ROICexc growth 3Y18.03%
ROICexc growth 5Y32.94%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 59.58 | ||
| Debt/EBITDA | 8.69 | ||
| Cap/Depr | 38.76% | ||
| Cap/Sales | 4.98% | ||
| Interest Coverage | 0.76 | ||
| Cash Conversion | 40.27% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 0.3 |
F-Score4
WACC4.35%
ROIC/WACC0.59
Cap/Depr(3y)38.9%
Cap/Depr(5y)51.85%
Cap/Sales(3y)4.13%
Cap/Sales(5y)4.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y270.48%
EBIT growth 3Y64.54%
EBIT growth 5Y115.95%
EBIT Next Year262.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.58%
FCF growth 3Y436.48%
FCF growth 5YN/A
OCF growth 1Y59.77%
OCF growth 3Y121.33%
OCF growth 5Y94.79%